================================================================================
MICROGLIA MARKER GENE VALIDATION REPORT
================================================================================

OBJECTIVE:
Validate that our pipeline correctly identifies microglia and that gene
expression matches the paper's main finding: "Gene expression profiles did
not differ between AD donors and non-demented elderly."

================================================================================
1. MARKER PRESENCE
================================================================================
Present: 20 genes
Missing: 2 genes

Missing genes:
  - TNF
  - IL6

================================================================================
2. EXPRESSION LEVELS (Mean counts by condition)
================================================================================


Identity Markers:
--------------------------------------------------------------------------------

CX3CR1:
  AD: mean=89.9, detection=91.7%
  CTR: mean=55.3, detection=77.8%
  CTR+: mean=21.1, detection=66.7%

P2RY12:
  AD: mean=69.7, detection=91.7%
  CTR: mean=52.3, detection=100.0%
  CTR+: mean=17.9, detection=66.7%

TMEM119:
  AD: mean=9.5, detection=91.7%
  CTR: mean=1.4, detection=22.2%
  CTR+: mean=4.4, detection=66.7%

AIF1:
  AD: mean=119.9, detection=100.0%
  CTR: mean=111.6, detection=100.0%
  CTR+: mean=294.0, detection=100.0%

CSF1R:
  AD: mean=123.2, detection=100.0%
  CTR: mean=78.7, detection=88.9%
  CTR+: mean=57.0, detection=100.0%

Myeloid Markers:
--------------------------------------------------------------------------------

ITGAM:
  AD: mean=9.3, detection=75.0%
  CTR: mean=2.3, detection=44.4%
  CTR+: mean=1.6, detection=33.3%

PTPRC:
  AD: mean=306.6, detection=100.0%
  CTR: mean=140.3, detection=100.0%
  CTR+: mean=254.9, detection=100.0%

CD68:
  AD: mean=10.0, detection=91.7%
  CTR: mean=3.2, detection=66.7%
  CTR+: mean=2.8, detection=66.7%

FCGR3A:
  AD: mean=546.6, detection=100.0%
  CTR: mean=340.3, detection=100.0%
  CTR+: mean=588.3, detection=100.0%

AD Risk Markers:
--------------------------------------------------------------------------------

TREM2:
  AD: mean=33.9, detection=100.0%
  CTR: mean=12.3, detection=66.7%
  CTR+: mean=12.1, detection=83.3%

APOE:
  AD: mean=55.2, detection=100.0%
  CTR: mean=15.5, detection=66.7%
  CTR+: mean=39.6, detection=100.0%

CD33:
  AD: mean=2.0, detection=50.0%
  CTR: mean=0.0, detection=0.0%
  CTR+: mean=0.3, detection=33.3%

MS4A6A:
  AD: mean=84.6, detection=100.0%
  CTR: mean=22.0, detection=66.7%
  CTR+: mean=37.2, detection=100.0%

Activation Markers:
--------------------------------------------------------------------------------

IL1B:
  AD: mean=8.6, detection=41.7%
  CTR: mean=0.1, detection=11.1%
  CTR+: mean=16.1, detection=50.0%

CD86:
  AD: mean=38.0, detection=100.0%
  CTR: mean=19.9, detection=66.7%
  CTR+: mean=30.5, detection=100.0%

CD163:
  AD: mean=18.5, detection=91.7%
  CTR: mean=1.7, detection=55.6%
  CTR+: mean=70.6, detection=100.0%

Homeostatic Markers:
--------------------------------------------------------------------------------

P2RY13:
  AD: mean=38.7, detection=100.0%
  CTR: mean=21.1, detection=88.9%
  CTR+: mean=36.2, detection=100.0%

SELPLG:
  AD: mean=20.3, detection=100.0%
  CTR: mean=16.4, detection=88.9%
  CTR+: mean=1.5, detection=50.0%

GPR34:
  AD: mean=16.1, detection=100.0%
  CTR: mean=14.6, detection=88.9%
  CTR+: mean=4.3, detection=66.7%

OLFML3:
  AD: mean=175.2, detection=100.0%
  CTR: mean=149.6, detection=88.9%
  CTR+: mean=33.1, detection=100.0%

================================================================================
3. DIFFERENTIAL EXPRESSION STATUS
================================================================================

According to the paper, microglia markers should NOT be significantly
different between AD and Control.

✓ Good: No markers are significantly DE (matches paper)

✓ 19 markers are NOT significantly DE (expected):
  MS4A6A: log2FC=1.58, padj=0.129
  ITGAM: log2FC=2.17, padj=0.226
  TREM2: log2FC=1.46, padj=0.232
  CD68: log2FC=1.72, padj=0.252
  TMEM119: log2FC=1.80, padj=0.300
  APOE: log2FC=1.12, padj=0.340
  PTPRC: log2FC=0.72, padj=0.397
  CSF1R: log2FC=0.81, padj=0.449
  SELPLG: log2FC=0.97, padj=0.533
  CX3CR1: log2FC=1.11, padj=0.535
  P2RY12: log2FC=0.85, padj=0.599
  GPR34: log2FC=0.63, padj=0.643
  AIF1: log2FC=-0.62, padj=0.644
  P2RY13: log2FC=0.51, padj=0.669
  OLFML3: log2FC=0.77, padj=0.676
  CD86: log2FC=0.65, padj=0.696
  CD163: log2FC=-0.66, padj=0.786
  FCGR3A: log2FC=0.31, padj=0.799
  IL1B: log2FC=0.38, padj=0.958

================================================================================
4. INTERPRETATION
================================================================================

Pipeline Validation:
✓ PASS: 90.9% of markers detected

Consistency with Paper:
✓ PASS: Only 0.0% of markers are DE (matches paper's finding)

================================================================================
FILES GENERATED
================================================================================
- marker_expression_boxplots.png: Individual gene expression by condition
- marker_expression_heatmap.png: Mean expression heatmap
- marker_statistics.csv: Detailed statistics per gene per condition
- marker_de_results.csv: DE results for markers (if available)
- VALIDATION_REPORT.txt: This report
